Volume 43, Issue 5, 1 February 2022

Issue @ A Glance

Treatment of heart failure across the spectrum of left ventricular ejection fraction and an update on cardiac amyloidosis and ischaemic cardiomyopathy

Filippo Crea

European Heart Journal, Volume 43, Issue 5, 1 February 2022, Pages 351–354, https://doi.org/10.1093/eurheartj/ehab906

• Extract
• View article

CardioPulse

Taking root: how a fresh approach to nutrition is tackling heart disease amongst South Asian populations

Judith Ozkan

European Heart Journal, Volume 43, Issue 5, 1 February 2022, Pages 355–356, https://doi.org/10.1093/eurheartj/ehab410

• Extract
• View article

The heart of FOIE GRAS and mtFOIE GRAS: fundamental and clinical investigation for training and innovation in non-alcoholic fatty liver disease

Paulo J Oliveira

European Heart Journal, Volume 43, Issue 5, 1 February 2022, Pages 357–359, https://doi.org/10.1093/eurheartj/ehab399

• Extract
• View article

Keeping pace with one of Israel’s leading cardiologists

Mark Nicholls

European Heart Journal, Volume 43, Issue 5, 1 February 2022, Pages 360–361, https://doi.org/10.1093/eurheartj/ehab361

• Extract
• View article

Environmental factors high on congress agenda

Mark Nicholls

European Heart Journal, Volume 43, Issue 5, 1 February 2022, Pages 362–364, https://doi.org/10.1093/eurheartj/ehab439

• Extract
• View article

CardioPulse

Weekly Journal Scan

Therapeutic-dose heparin should integrate the standard of care of moderately ill patients with COVID-19 admitted to hospital

Giovanna Liuzzo and Carlo Patrono

European Heart Journal, Volume 43, Issue 5, 1 February 2022, Pages 365–366, https://doi.org/10.1093/eurheartj/ehab812

• Extract
• View article

Special Article

The year in cardiovascular medicine 2021: heart failure and cardiomyopathies

Johann Bauersachs and others

European Heart Journal, Volume 43, Issue 5, 1 February 2022, Pages 367–376, https://doi.org/10.1093/eurheartj/ehab887

• Abstracts
• View article

The year in cardiovascular medicine 2021: interventional cardiology

Javier Escaned and others

European Heart Journal, Volume 43, Issue 5, 1 February 2022, Pages 377–386, https://doi.org/10.1093/eurheartj/ehab884

• Abstracts
• View article

Viewpoint

Heart failure and cardiomyopathies

Myocardial revascularization in ischaemic cardiomyopathy: routine practice vs. scientific evidence

Raffaele De Caterina and others

European Heart Journal, Volume 43, Issue 5, 1 February 2022, Pages 387–390, https://doi.org/10.1093/eurheartj/ehab680

• Abstract
• View article

Clinical Research

Heart failure and cardiomyopathies

Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS)

Thibaud Damy and others

European Heart Journal, Volume 43, Issue 5, 1 February 2022, Pages 391–400, https://doi.org/10.1093/eurheartj/ehz173

• Abstract
• View article
• Supplementary data

Editorial

Transthyretin amyloidosis in Western Europe: a snapshot from the THAOS registry and a call for further perspectives

Enrico Ammirati and Omar F AbouEzzeddine

European Heart Journal, Volume 43, Issue 5, 1 February 2022, Pages 401–404, https://doi.org/10.1093/eurheartj/ehz205

• Extract
• View article

Heart failure and cardiomyopathies

Primary care heart failure service identifies a missed cohort of heart failure patients with reduced ejection fraction

Matthew Kahn and others

European Heart Journal, Volume 43, Issue 5, 1 February 2022, Pages 405–412, https://doi.org/10.1093/eurheartj/ehab629

• Abstracts
• View article

Editorial

Implementation science and potential for screening in heart failure

Lars H Lund and others

European Heart Journal, Volume 43, Issue 5, 1 February 2022, Pages 413–415, https://doi.org/10.1093/eurheartj/ehab751

• Abstract
• View article

Heart failure and cardiomyopathies

Editor's Choice

Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction

Javed Butler and others

European Heart Journal, Volume 43, Issue 5, 1 February 2022, Pages 416–424, https://doi.org/10.1093/eurheartj/ehab798

• Abstracts
• View article
• Supplementary data

Editorial

Re-emergence of heart failure with a normal ejection fraction?

Toru Kondo and John J V McMurray

European Heart Journal, Volume 43, Issue 5, 1 February 2022, Pages 427–429, https://doi.org/10.1093/eurheartj/ehab828

• Abstract
• View article

Discussion Forum

Respectful language and putting the person first with obesity

Simar Singh Bajaj and others

European Heart Journal, Volume 43, Issue 5, 1 February 2022, Page 430, https://doi.org/10.1093/eurheartj/ehab837

• Extract
• View article

Investigating the disease is the key to the obesity stigma

Jennifer J Rayner and Oliver J Rider

European Heart Journal, Volume 43, Issue 5, 1 February 2022, Page 431, https://doi.org/10.1093/eurheartj/ehab840

• Extract
• View article

Cardiovascular Flashlight

‘Targeting the cardiac myocyte and fibrosis’ in heart failure

Junko Ishiura and others

European Heart Journal, Volume 43, Issue 5, 1 February 2022, Page 432, https://doi.org/10.1093/eurheartj/ehab780

• Extract
• View article
• Supplementary data

Simultaneous transcatheter aortic mitral and tricuspid valve-in-valve implantation

Deguang Feng and others

European Heart Journal, Volume 43, Issue 5, 1 February 2022, Page 433, https://doi.org/10.1093/eurheartj/ehab339

• Extract
• View article

Corrigendum

Corrigendum to: AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial

Michele Brignole and others

European Heart Journal, Volume 43, Issue 5, 1 February 2022, Page 386, https://doi.org/10.1093/eurheartj/ehab831

• Extract
• View article